$729 Million is the total value of Eversept Partners, LP's 69 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 68.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $104,842,400 | +577.9% | 340,000 | +466.7% | 14.38% | +273.9% |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $53,064,338 | – | 954,738 | +100.0% | 7.28% | – |
| TGTX | Buy | TG THERAPEUTICS INC | $48,724,779 | +101.2% | 2,501,272 | +1.6% | 6.68% | +11.0% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $33,119,819 | +136.3% | 4,786,101 | +36.6% | 4.54% | +30.4% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $32,772,581 | +805.2% | 448,264 | +321.4% | 4.49% | +399.3% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $32,588,878 | +5.0% | 220,344 | -20.0% | 4.47% | -42.1% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $29,732,166 | +88.8% | 562,151 | +59.5% | 4.08% | +4.2% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $28,153,796 | – | 232,676 | +100.0% | 3.86% | – |
| ZGNX | Sell | ZOGENIX INC | $27,201,312 | -45.4% | 1,007,083 | -50.0% | 3.73% | -69.9% |
| HSKA | Buy | HESKA CORP | $26,111,452 | +2173.3% | 280,256 | +1249.3% | 3.58% | +1152.1% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $25,001,897 | +46.7% | 418,652 | +1.1% | 3.43% | -19.1% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $23,099,729 | +53.1% | 4,847,792 | -35.7% | 3.17% | -15.5% |
| DHR | Sell | DANAHER CORPORATION | $19,089,983 | -41.1% | 107,857 | -53.9% | 2.62% | -67.5% |
| FATE | Buy | FATE THERAPEUTICS INC | $18,227,462 | +168.7% | 531,258 | +73.9% | 2.50% | +48.1% |
| ENSG | Buy | ENSIGN GROUP INC | $17,904,163 | +33.2% | 427,307 | +19.7% | 2.46% | -26.5% |
| MYOV | New | MYOVANT SCIENCES LTD | $15,682,562 | – | 760,551 | +100.0% | 2.15% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $13,747,639 | -42.9% | 420,932 | -53.2% | 1.88% | -68.5% |
| MODN | Sell | MODEL N INC | $11,844,957 | +42.5% | 340,764 | -9.0% | 1.62% | -21.4% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $11,501,349 | – | 71,731 | +100.0% | 1.58% | – |
| GSK | Sell | GLAXOSMITHKLINE PLCsponsored adr | $9,270,058 | -53.3% | 227,263 | -55.5% | 1.27% | -74.3% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $9,265,074 | – | 712,698 | +100.0% | 1.27% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $8,910,281 | – | 548,325 | +100.0% | 1.22% | – |
| XLV | New | SELECT SECTOR SPDR TRput | $8,005,600 | – | 80,000 | +100.0% | 1.10% | – |
| AMRN | Buy | AMARIN CORP PLCcall | $7,475,676 | +82.6% | 1,080,300 | +5.5% | 1.02% | +0.7% |
| LQDA | Buy | LIQUIDIA TECHNOLOGIES INC | $7,238,876 | +528.2% | 859,724 | +251.4% | 0.99% | +247.2% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $6,992,687 | +49.4% | 105,169 | +37.5% | 0.96% | -17.5% |
| PCRX | New | PACIRA BIOSCIENCES | $6,960,408 | – | 132,655 | +100.0% | 0.95% | – |
| MYOK | Buy | MYOKARDIA INC | $6,820,792 | +424.3% | 70,594 | +154.4% | 0.94% | +189.5% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $4,551,794 | +185.5% | 350,138 | +103.3% | 0.62% | +57.6% |
| AFMD | Buy | AFFIMED N V | $4,351,894 | +391.1% | 942,989 | +68.2% | 0.60% | +171.4% |
| AMRX | New | AMNEAL PHARMACEUTICALS INC | $4,220,154 | – | 886,587 | +100.0% | 0.58% | – |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $4,141,511 | +229.2% | 258,360 | +23.0% | 0.57% | +81.5% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $4,136,725 | +3.8% | 124,338 | -15.2% | 0.57% | -42.8% |
| QGEN | New | QIAGEN NV | $3,530,369 | – | 82,466 | +100.0% | 0.48% | – |
| CYTK | Sell | CYTOKINETICS INC | $3,339,869 | +55.9% | 141,700 | -22.0% | 0.46% | -14.1% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $3,274,187 | +198.2% | 128,905 | +115.7% | 0.45% | +64.5% |
| RDUS | Sell | RADIUS HEALTH INC | $3,000,099 | -23.3% | 220,110 | -26.9% | 0.41% | -57.8% |
| HCA | Sell | HCA HEALTHCARE INC | $2,950,624 | -67.5% | 30,400 | -69.9% | 0.40% | -82.0% |
| VAPO | New | VAPOTHERM INC | $2,943,861 | – | 71,819 | +100.0% | 0.40% | – |
| ALGN | ALIGN TECHNOLOGY INCput | $2,744,400 | +57.8% | 10,000 | 0.0% | 0.38% | -13.0% | |
| DXCM | Sell | DEXCOM INC | $2,704,018 | -48.6% | 6,670 | -65.9% | 0.37% | -71.6% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $2,544,077 | +447.1% | 583,504 | +375.5% | 0.35% | +200.9% |
| SNY | Sell | SANOFIsponsored adr | $2,541,167 | -69.3% | 49,778 | -73.7% | 0.35% | -83.1% |
| CCXI | Sell | CHEMOCENTRYX INC | $2,350,049 | -89.9% | 40,842 | -93.0% | 0.32% | -94.4% |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $2,318,181 | – | 232,983 | +100.0% | 0.32% | – |
| PNTG | Sell | PENNANT GROUP INC | $2,318,037 | -42.0% | 102,568 | -63.7% | 0.32% | -68.0% |
| OTIC | Buy | OTONOMY INC | $2,176,210 | +96.7% | 601,163 | +7.0% | 0.30% | +8.4% |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $2,081,716 | – | 81,700 | +100.0% | 0.28% | – |
| ALBO | ALBIREO PHARMA INC | $2,066,988 | +61.8% | 78,029 | 0.0% | 0.28% | -11.0% | |
| FLDM | New | FLUIDIGM CORP DEL | $1,876,371 | – | 467,923 | +100.0% | 0.26% | – |
| SCPH | Buy | SCPHARMACEUTICALS INC | $1,821,004 | +85.8% | 247,419 | +86.8% | 0.25% | +2.5% |
| PRTA | New | PROTHENA CORP PLC | $1,592,148 | – | 152,213 | +100.0% | 0.22% | – |
| CYH | Sell | COMMUNITY HEALTH SYS INC NEW | $1,481,739 | -23.6% | 492,272 | -15.2% | 0.20% | -57.9% |
| CYCN | Sell | CYCLERION THERAPEUTICS INC | $1,463,688 | +63.8% | 247,663 | -26.5% | 0.20% | -9.5% |
| ZYME | New | ZYMEWORKS INC | $1,442,800 | – | 40,000 | +100.0% | 0.20% | – |
| SESN | Buy | SESEN BIO INC | $1,440,000 | +97.6% | 2,000,000 | +53.8% | 0.20% | +8.8% |
| TARA | New | PROTARA THERAPEUTICS INC | $1,357,809 | – | 46,310 | +100.0% | 0.19% | – |
| XOMA | New | XOMA CORP DEL | $1,265,747 | – | 64,056 | +100.0% | 0.17% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $1,192,580 | – | 407,024 | +100.0% | 0.16% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $1,086,653 | – | 89,806 | +100.0% | 0.15% | – |
| QURE | New | UNIQURE NV | $1,033,136 | – | 22,928 | +100.0% | 0.14% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $867,486 | – | 97,800 | +100.0% | 0.12% | – |
| New | TELIGENT INC NEW | $859,095 | – | 354,998 | +100.0% | 0.12% | – | |
| BNR | New | BURNING ROCK BIOTECH LTDsponsored ads | $810,300 | – | 30,000 | +100.0% | 0.11% | – |
| AL | AIR LEASE CORPput | $585,800 | +32.3% | 20,000 | 0.0% | 0.08% | -27.3% | |
| OSMT | New | OSMOTICA PHARMACEUTICALS PLC | $531,919 | – | 79,037 | +100.0% | 0.07% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $470,477 | -0.7% | 49,008 | -29.7% | 0.06% | -44.9% |
| IMVT | Sell | IMMUNOVANT INC | $298,677 | -75.0% | 12,266 | -84.0% | 0.04% | -86.2% |
| ZGNX | ZOGENIX INCcall | $148,555 | +9.2% | 5,500 | 0.0% | 0.02% | -41.2% | |
| PFNX | Exit | PFENEX INC | $0 | – | -46,293 | -100.0% | -0.10% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -3,153 | -100.0% | -0.11% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -58,251 | -100.0% | -0.12% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -91,998 | -100.0% | -0.13% | – |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -9,770 | -100.0% | -0.14% | – |
| AMRN | Exit | AMARIN CORP PLCput | $0 | – | -150,000 | -100.0% | -0.15% | – |
| AQST | Exit | AQUESTIVE THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.16% | – |
| TARA | Exit | ARTARA THERAPEUTICS INC | $0 | – | -32,478 | -100.0% | -0.19% | – |
| IFRX | Exit | INFLARX NV | $0 | – | -195,488 | -100.0% | -0.19% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -71,591 | -100.0% | -0.20% | – |
| TLGT | Exit | TELIGENT INC NEW | $0 | – | -3,862,903 | -100.0% | -0.27% | – |
| AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -711,756 | -100.0% | -0.33% | – |
| NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -109,212 | -100.0% | -0.41% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -524,257 | -100.0% | -0.54% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -90,047 | -100.0% | -0.67% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -42,305 | -100.0% | -0.94% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -975,350 | -100.0% | -1.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.